MONDAY, Nov. 17, 2025 — The U.S. Food and Drug Administration (FDA) is tightening restrictions on a gene therapy used to treat Duchenne muscular dystrophy after two teenagers died from liver failure linked to the medication.
The FDA decision…
Blog
Leave a Reply